Randomized crossover study in patients with neuroendocrine tumors to assess patient preference for lanreotide Autogel(®) given by either self/partner or a health care professional.
about
Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumorsPharmacoeconomic aspects of the treatment of pituitary gland tumours.Patient-focussed outcomes in acromegaly.Optimizing Somatostatin Analog Use in Well or Moderately Differentiated Gastroenteropancreatic Neuroendocrine Tumors.Development of a Framework Based on Reflective MCDA to Support Patient-Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United States.Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE).
P2860
Randomized crossover study in patients with neuroendocrine tumors to assess patient preference for lanreotide Autogel(®) given by either self/partner or a health care professional.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Randomized crossover study in ...... or a health care professional.
@ast
Randomized crossover study in ...... or a health care professional.
@en
type
label
Randomized crossover study in ...... or a health care professional.
@ast
Randomized crossover study in ...... or a health care professional.
@en
prefLabel
Randomized crossover study in ...... or a health care professional.
@ast
Randomized crossover study in ...... or a health care professional.
@en
P2093
P2860
P356
P1476
Randomized crossover study in ...... or a health care professional
@en
P2093
Anders Ohberg
Anna Abrahamsson
Benedicte Wilson
Constantin Jianu
Dan Granberg
Jon Florholmen
Najme Wall
Viktor Johanson
P2860
P304
P356
10.2147/PPA.S34337
P407
P577
2012-10-17T00:00:00Z